LIFECORE BIOMEDICAL, INC. Long-term Debt, Gross
LIFECORE BIOMEDICAL, INC. (LFCR) had Long-term Debt, Gross of $203.92 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-08-05
- 2026-06-30: Long-term Debt, Gross $203.92M.
- 2026-03-31: Long-term Debt, Gross $200.06M.
- 2025-12-31: Long-term Debt, Gross $195.76M.
- 2025-09-30: Long-term Debt, Gross $191.47M.
| Period end | Long-term Debt, Gross | Long-term Debt, Gross as first filed |
|---|---|---|
| 2026-06-30 | $203.92M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $200.06M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $195.76M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $191.47M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $188.35M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $184.36M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $172.04M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $168.20M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $187.54M 10-KT · filed 2026-03-16 | $164.46M 10-K · filed 2024-08-26 |
| 2024-02-25 | $160.82M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $157.27M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $153.82M 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $150.23M 10-K · filed 2024-08-26 | |
| 2023-02-26 | $107.08M 10-Q · filed 2023-06-02 | |
| 2022-11-27 | $103.71M 10-Q · filed 2023-03-16 | |
| 2022-08-28 | $103.71M 10-Q/A · filed 2023-03-16 | |
| 2022-05-29 | $103.71M 10-K · filed 2024-03-20 | |
| 2022-02-27 | $83.71M 10-Q · filed 2022-04-07 | |
| 2021-11-28 | $128.65M 10-Q · filed 2022-01-07 | |
| 2021-08-29 | $128.65M 10-Q · filed 2021-10-05 | |
| 2021-05-30 | $170.00M 10-K/A · filed 2023-03-16 | |
| 2021-02-28 | $150.00M 10-Q · filed 2021-04-08 | |
| 2020-11-29 | $94.00M 10-Q · filed 2021-01-07 | |
| 2020-08-30 | $106.00M 10-Q · filed 2020-10-07 | |
| 2020-05-31 | $114.00M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $117.00M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $120.00M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $95.00M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $97.50M 10-K · filed 2020-08-14 | |
| 2019-02-24 | $100.00M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $40.00M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $41.25M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $42.50M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $43.75M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $45.00M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $46.25M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $47.50M 10-K · filed 2018-08-09 | |
| 2017-02-26 | $48.75M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $50.00M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $52.77M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $54.66M 10-K/A · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |